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Intracranial aneurysms are present in roughly 5% of the population, yet most are often
asymptomatic and never detected. Development of an aneurysm typically occurs during
adulthood, while formation and growth are associated with risk factors such as age, hyper-
tension, pre-existing familial conditions, and smoking. Subarachnoid hemorrhage, themost
common presentation due to aneurysm rupture, represents a serious medical condition
often leading to severe neurological deﬁcit or death. Recent technological advances in imag-
ing modalities, along with increased understanding of natural history and prevalence of
aneurysms, have increased detection of asymptomatic unruptured intracranial aneurysms
(UIA). Studies reporting on the risk of rupture and outcomes have provided much insight,
but the debate remains of how and when unruptured aneurysms should be managed.
Treatment methods include two major intervention options: clipping of the aneurysm and
endovascular methods such as coiling, stent-assisted coiling, and ﬂow diversion stents.
The studies reviewed here support the generalized notion that endovascular treatment of
UIA provides a safe and effective alternative to surgical treatment.The risks associatedwith
endovascular repair are lower and incur shorter hospital stays for appropriately selected
patients. The endovascular treatment option should be considered based on factors such
as aneurysm size, location, patient medical history, and operator experience.
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INTRODUCTION
Subarachnoid hemorrhage (SAH) is the most serious presenta-
tion of ruptured intracranial aneurysms. Autopsy reports have
shown that aneurysms are present in roughly 5% of the popu-
lation, yet most are often asymptomatic (Menghini et al., 1998;
Iwamoto et al., 1999; Winn et al., 2002). Estimated annual inci-
dence rates of SAH range from 10 to 15 cases per 100,000, which
translates to at least 30,000 annual cases of SAH in the United
States. Two-thirds of patients with aneurysm rupture either die
or have a disabling neurological deﬁcit (Stapf and Mohr, 2004).
In recent years, an increasing number of unruptured, incidental
aneurysms are being detected due to increased availability of non-
invasive imaging modalities. While it is clear that most ruptured
aneurysms must be treated to prevent rerupture, the management
Abbreviations: ATENA, analysis of treatment by endovascular approach of non-
ruptured aneurysms; CSF, cerebral spinal ﬂuid; CT, computerized tomography;
FDA, Food and Drug Administration; GDC, Guglielmi detachable coils; ISAT,
International subarachnoid aneurysms trial.; ISUIA, The International Study of
Unruptured Intracranial Aneurysms; MCA, middle cerebral artery; MRA, mag-
netic resonance angiography; SAH, subarachnoid hemorrhage; UIA, unruptured
intracranial aneurysm;WSS, wall shear stress.
of the unruptured intracranial aneurysms (UIA) is more complex
both from treatment decision making perspectives.
Aneurysms typically develop during adulthood and rupture
risk increases with age. The mean age for aneurysmal SAH is
about 50 years (Phillips et al., 1980). Typical locations at risk for
the development of aneurysms are branching points (Meng et al.,
2007), where structural irregularities in the collagen matrix exist
(Finlay et al., 1998; Rowe et al., 2003), and elevated hemodynamic
stresses due to segments involving short radii of curvature are
more observed. Studies have shown that abnormal hemodynamic
stress plays an important role in aneurysm formation and growth
(Meng et al., 2007).
Intracranial aneurysms can be classiﬁed using several schemes.
Themost obvious division is considering the ruptured and unrup-
tured lesions separately. With respect to morphology, aneurysms
are classiﬁed as saccular or non-saccular. Non-saccular intracra-
nial aneurysms such as fusiform, dolichoectatic, and dissecting
aneurysms are rare with an incidence of less than 0.1% (Anson
et al., 1996). Another system of classiﬁcation is by aneurysm loca-
tion. The predominant location for saccular aneurysms is the ante-
rior circulation (90%), with most arising from the circle of Willis
(Bonneville et al., 2006). The anterior communicating complex
(30–35%) is the most common location, followed by the internal
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carotid artery (30%). The basilar apex represents the most com-
mon location in the posterior circulation and accounts for 10% of
all intracranial aneurysms (Bonneville et al., 2006). Aneurysms
are also classiﬁed by size into subgroups of small (< 10mm),
large (10–25mm), and giant (> 25mm) in diameter. According
to Wiebers et al. (2003), aneurysms smaller than 12mm in dome
size account formore than 75%of the unruptured aneurysms. The
establishment of endovascular therapy has led to further classiﬁ-
cation of aneurysms based on the size of the neck. Management
of UIA remains a topic of debate due to incomplete and often
conﬂicting data relating to the natural history of aneurysms, along
with the risks associated with treatment (Chen et al., 2004).
While published studies may present different aneurysm rup-
ture risk levels, they all indicate that treatment is recommended
due to the poor outcome of rupture. Ruptured aneurysms account
for approximately 85% of non-traumatic SAH and are associated
with a 30-day mortality rate of 45% and a morbidity rate of 25%
(van Gijn et al., 2007). In a study of hospital discharge records
for patients with ruptured and unruptured aneurysms, mortality
rates for SAH demonstrated little change with the introduction
of endovascular treatments (Qureshi et al., 2005). In addition to
poor outcomes and co-morbidities resulting from SAH, economic
burden associated with SAH must also be taken into considera-
tion. Dodel et al. (2010) recently published a study on the cost
of illness due to SAH, the total accumulated costs in the ﬁrst year
were € 38,300 (95%CI, € 34,490 to € 43,100). Their data also indi-
cate higher costs associated with younger patients. The method of
treatment for ruptured intracranial aneurysms, however, remains
a problem with no clear solution (Bederson et al., 2000).
CEREBROVASCULAR ANATOMY AND PATHOPHYSIOLOGY OF
ANEURYSMS
It is suggested that formation of an intracranial aneurysm is a
consequence of a systemic vascular pathology, which is associ-
ated with pleomorphism in different candidate genes (Toth et al.,
2000; Krex et al., 2001; Yurt et al., 2010). A higher prevalence
of aneurysms in the cerebrovascular system may also be due to
alterations in hemodynamic and histological characteristics (Ste-
hbens, 1990; Kondo et al., 1997; Rowe et al., 2003; Shojima et al.,
2004). Cerebral arteries are particularly susceptible to aneurysm
formation due to the absence of an external elastic lamina, paucity
of supportive perivascular tissues, attenuated tunica media, and
irregularities near bifurcations (Stehbens, 1990; Rowe et al., 2003).
The internal elastic lamina is an important layer of the arterial wall,
especially in the cerebral vessels. Thus, disruption of this layer
would promote formation of aneurysms (Yong-Zhong and van
Alphen, 1990). Particularly, the regions around the bifurcations
have atypical wall structures with a discontinuity of the muscle
cells of the tunica media as a medial defect in connection with a
predominance of collagen ﬁbers over the elastic ones (Rowe et al.,
2003; Swietaszczyk et al., 2004). In addition to this speciﬁc struc-
ture, non-uniform collagen framework in the bifurcation region
of brain arteries may further induce development of intracranial
aneurysms develop (Rowe et al., 2003).
Swietaszczyk et al. (2004) demonstrated that arterial blood
ﬂow disturbance and hypertension in the brain vessels lead to
increased hemodynamic stress on arterial walls. Some studies also
present strong association between wall shear stress (WSS) and
initiation of cerebral aneurysm formation in experimental models
(Kondo et al., 1997; Shojima et al., 2004). A prolonged high WSS
induces matrix metalloproteinase production and fragmentation
of the internal elastic lamina at, or immediately adjacent to the
apex, the bifurcation (Masuda et al., 1999; Shojima et al., 2004;
Meng et al., 2007). Prolonged elevation of blood pressure leads to
excessivemechanical loading and causes remodeling of the arterial
wall. The exact mechanisms involved in this tissue remodeling are
not completely understood, but the decreased structural integrity
of the tissue may be one of the underlying reasons of aneurysm
formation and growth.
RISK OF ANEURYSM RUPTURE
The International study of unruptured intracranial aneurysms
(ISUIA) has been the most comprehensive clinical study of its
kind to date (The International Study of Unruptured Intracranial
Aneurysms Investigators, 1998). The study enrolled 4,060 patients
from the US, Canada, and Europe. In phase II of ISUIA trial, there
were a total of 6,221 unruptured aneurysms among different stud-
ied cohorts (i.e., operated and unoperated; Wiebers et al., 2003).
A higher rupture rate was reported to be associated with larger
aneurysms, location in the posterior circulation, and previous his-
tory of SAH. The 5-year cumulative rupture rate, for patients with
no history of SAH and aneurysm size between 7 and 12mm, was
2.6 and 14.5% for aneurysms located in the anterior and poste-
rior circulation, respectively. The greatest risk of rupture, for large
size aneurysms in the posterior circulation, was 50% (Wiebers
et al., 2003). Juvela et al. (2000) followed 142 patients with 181
aneurysms for a total of 2,575 person years and reported a rupture
rate of 1.46% per year (95% CI: 1.04–2.04). Rinkel et al. (1998)
presented data on nine studies, totaling 3,907 patient years and
similarly concluded a rupture rate of 1.9% (95% CI: 1.5–2.4).
Prevalence of aneurysms and rupture risks were shown to increase
in both studies due to the factors such as size of the unruptured
aneurysm, age of the patient, pre-existing familial conditions, and
hypertension. Smoking has been also associatedwith higher preva-
lence aneurysms and rate of rupture (Juvela et al., 2001). More
recent studies have begun to focus on additional quantiﬁcation
methods of aneurysms to predict rupture risks. Several geo-
metric indices, measured by using three-dimensional rotational
angiography or digital subtraction angiography, have correlated
to increased rupture rates. Ryu et al. (2010) compared geomet-
ric indicators of 109 unruptured and 105 ruptured aneurysms to
develop imaging predictor markers of aneurysm rupture. The two
highest indicatorswere the aspect ratio (the ratio of the aneurysm’s
height to its neck) and the volume to neck ratio. From the pub-
lished data in the literature, larger aneurysms have an increased
risk of rupture. Raghavan et al. (2005) noted that two other fac-
tors, the undulation index and the non-sphericity index, are strong
predictors of aneurysm rupture as well.
TREATMENT OPTIONS
SURGICAL CLIPPING
The ﬁrst direct operation on an intracranial aneurysm was per-
formed by Norman Dott in 1931 (Dott, 1933). In 1937, Walter
Dandy performed the ﬁrst operation for clipping an intracranial
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aneurysm, inwhich he applied a silver clip across the neck of a pos-
terior communicating artery aneurysm (Chyatte, 1996; Chicoine,
2003). Introduction of operative microscopes, development of
dedicated aneurysm clips, and development of advanced surgi-
cal approaches were instrumental to improving outcomes from
aneurysm surgery. Factors such as site, size, and age-speciﬁc risks
of repair for each patient should be considered in the treatment of
UIA (Wiebers et al., 2003).
A detailed description of open surgical technique for aneurysm
clipping is beyond the scope of this review. Some important steps
include patient positioning, planning of the craniotomy, and a
microsurgical approach to clipping of the aneurysm. Depending
on the location of the aneurysm, speciﬁc arachnoidal dissection
is necessary to obtain proximal control of the parent artery. Once
this is achieved, the aneurysm can be exposed and dissected under
high magniﬁcation. The middle cerebral artery (MCA) bifur-
cation aneurysms serve as examples of the various approaches
available.
There are three different approaches to expose the MCA
aneurysm in the sylvian ﬁssure. The sylvian ﬁssure can be opened
frommedial (proximal) to lateral (distal) or vice versa. The lateral
to medial approach requires less brain retraction and is usually
more direct to these superﬁcial aneurysms (Roberts and Dacey,
2004). Alternatively, an incision in the superior temporal gyrus
with subpial resection can be used to expose the aneurysm (Ogilvy
et al., 1995). This approachmaybe particularly usefulwhen there is
an associated temporal lobe hematoma. Thereafter, routinely the
parent artery is prepared for temporary clipping before deploy-
ment of the permanent clips (Chyatte and Porterﬁeld, 2001).
Temporary clipping of the parent artery is useful in the event
of an intraoperative aneurysm rupture. Moreover, it is useful to
reduce the turgor of the aneurysm and facilitate permanent clip
application across the aneurysm neck. However, there may be a
higher risk of ischemic complications with temporary clipping
(Lavine et al., 1997). Prior to temporary clipping, blood pressure
may be elevated pharmacologically and cerebral protectants such
as barbiturates, propofol, or etomidate can be administered to
reduce the risk of ischemia. Finally, after placement of the perma-
nent clip on the aneurysmal neck, intraoperative micro-Doppler,
non-invasive near infrared indocyanine green videoangiography,
or invasive intraoperative cerebral angiography are employed to
assess the patency of the parent artery aswell as the entire occlusion
of the aneurysm neck (Raabe et al., 2005; Dashti et al., 2007).
A case of clipping of a right MCA aneurysm is illustrated in
Figure 1.
ENDOVASCULAR COILING
In 1939, the ﬁrst endovascular treatment of an intracranial
aneurysm was performed, in which 30 feet of silver wire were
placed into a giant cavernous carotid aneurysm that had eroded
the orbit (Werner et al., 1941). In Luessenhop and Velasquez
(1964) ﬁrst described catheterization of the intracranial arteries
and catheter based embolization of an intracranial aneurysm. In
the early 1970s, Serbinenko (1974), considered by many to be
the founder of endovascular neurosurgery, developed a series of
balloon mounted ﬂow guided catheters and detachable balloons
designed to occlude intracranial vascular lesions. In the 1980s and
early 1990s, Guglielmi et al. (1991a,b) combined the concepts
of electrothrombosis and endovascular approaches to develop a
detachable coil system. Guglielmi detachable coils (GDC) were
approved by the Food and Drug Administration (FDA) and form
the basis of contemporary endovascular treatment of intracra-
nial aneurysms. Endovascular therapy for aneurysms is attractive
because an effective and often equivalent result can be achieved
with a less invasive method compared to traditional micro-
surgery. This may result in decreased hospitalization and faster
recovery times for the patient (Johnston, 2000; Higashida et al.,
2007).
The following is an overview of the key steps of the coil
embolization procedure. The procedure can be performed under
general anesthesia or conscious sedation depending on the
patient’s ability to cooperate, the complexity of the aneurysm, and
the operator’s preference. Aneurysm coiling is typically performed
using biplane ﬂuoroscopic guidance. A typical procedure involves
gaining access to the common femoral artery and navigating a
guide catheter, ranging from 5 to 7 French in diameter, into the
internal carotid artery or vertebral artery.Amicrocatheter, ranging
in size from 1.7 to 2.3 French, is then advanced over a microwire
(typically 0.014′′). Once the best projection of the aneurysm is
obtained (i.e., a view that clearly delineates the aneurysm neck and
surrounding arterial branches), themicrocatheter is advanced into
the aneurysm. Platinum coils of various conﬁgurations and sizes
are deployed and detached through the microcatheter. The coils
are detached using either a hydraulic or electrolytic mechanism.
FIGURE 1 | Clipping of MCA aneurysm. A 49-year-old woman presented
with subarachnoid hemorrhage. (A) Cerebral angiography demonstrated a
6-mm right MCA bifurcation aneurysm. Like most MCA aneurysms, this
lesion had a wide neck involving the origins of the insular (M2) MCA divisions.
(B) A right frontotemporal craniotomy and sylvian ﬁssure opening was
performed with microsurgical exposure of the aneurysm. (C) A single clip was
applied across the aneurysm neck. (D) Postoperative angiography conﬁrmed
complete clipping (arrows) of the aneurysm.
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In general terms, the ﬁrst coil is either sized or slightly under-
sized to the maximum diameter of the aneurysm. For example, a
7-mm coil would be a reasonable ﬁrst coil for a 7.3-mm diameter
aneurysm. After framing coils are placed, the subsequent coils are
two-dimensional “ﬁlling” or “ﬁnishing” coils. Additional coils are
deployed until the aneurysm is no longer ﬁlling with contrast or
until additional coils cannot be placed safely. The latter condition
is often represented by either the ﬁnal coil or the microcatheter
protruding into the parent artery. There are a variety of micro-
catheters,microwires, and coils available in themarket. The choice
of device depends on the vascular tortuosity, the navigability and
stability of the catheter, and ultimately operator preference. Up to
2004, more than 125,000 patients with ruptured and unruptured
aneurysms had been treated with the GDC system (Pereira, 2003).
Figure 2 illustrates a case study of coil embolization procedure for
an aneurysm.
The early experience with coiling tended to be limited to
aneurysms with narrow necks. Wide necked aneurysms, deﬁned
from an endovascular standpoint as those with a dome-to-neck
ratio> 2 or an absolute neck diameter> 4mm,were not amenable
to coil embolization until technological advancements in the
late 1990s and early 2000s. Three major advancements have
expanded the indications for coil embolization of these wide-neck
aneurysms. First, the introduction of three-dimensional coils has
allowed for complex framing conﬁgurations to be achieved with
less coil protrusion into the parent artery. Second, the development
of balloon assisted coil embolization has allowed for improved
packing density of coils and also reduces the risk of coil protru-
sion into the parent vessel. In this technique, a compliant balloon
is navigated and inﬂated across the neck of an aneurysm as coils
are introduced into the aneurysm through the microcatheter. The
balloon can also arrest ﬂow in the parent artery in the event of an
intraprocedural aneurysm rupture (an example of balloon assisted
coil embolization is shown in Figure 3). Finally, stent-assisted coil
embolization has allowed for treatment of the very wide necked
aneurysms and diffusely diseased segments of arteries. Themicro-
catheter can be navigated through the pores of the stent into the
aneurysm or can be trapped between the artery wall and the stent.
In addition to improving coil packing density and preventing coil
protrusion, the stent may divert ﬂow away from the aneurysm
and allow vessel remodeling. Currently available stents include
Enterprise stent system (Codman, J&J, Raynham, MA, USA) and
Neuroform stent system (Stryker, Kalamazoo, MI, USA).
Murayama et al. (2003) described a single center experience
with GDCs during an 11-year period from 1990–2002. A total
of 916 aneurysms in 818 patients were treated by coiling and
results were separated into patients treated before and after FDA
approval of coils. This study included patients with acute SAH
(49%), unruptured aneurysms (42%), and non-acute SAH (9%).
Three hundred thirty-four aneurysms (36.5%) were small, 198
(21.6%) were large, 73 (8%) were giant. The overall results were
complete occlusion in 504 (55%) of 916 aneurysms, and a neck
remnant was seen in 234 (35.4%). Complete occlusion was highest
(86.2%) in small diameter and small neck aneurysms, the occlu-
sion rate was reduced by approximately half in the other groups,
which subsquenlty had increases in the amount of neck remants.
Another study byGonzalez et al. (2004), examined 247UIA treated
at the UCLA Medical Center during a similar time period (1991–
2000).Of thoseUIA’s,118 (54.4%)were found incidentially during
angiography,CT angiography,orMRangiograghy, and 51 (23.5%)
presentedwithmass effect. Angiographic results indicate complete
occlusion was achieved in 138 (55%) of 247 aneurysms, incom-
plete occlusion in 3 (1.2%), and neck remnants in 92 (37.2%).
Further evaulation of the results, stratiﬁed into the aneurysm size
groups described in theMurayama et al. (2003) study, show higher
success rates for complete occlusion in smaller aneurysms. Of the
83 small aneurysms with narrow necks, 63 (75%) were completely
occluded,while 20 (23.8%) had a neck remnamt. As aneurysm size
increased, the likeliness of complete occlusionwas greatly reduced,
with success being achieved in 7 (24.1%) of 29 giant aneurysms.
Wanke et al. (2002) published endovascular treatment results of 39
patients harboring 42 unruptured aneurysms. The study included
18 small (0–5mm), 11 medium (6–10mm), 9 large (11–25mm),
and 4 giant (> 25mm) aneurysms. Endovascular treatment was
FIGURE 2 | Recanalized aneurysm. A 59-year-old man presented with
SAH found to have multiple aneurysms including a giant anterior
communicating artery (ACoA) aneurysm. He underwent primary coil
embolization initially. (A) Anterior–posterior (AP) view of a right ICA
injection shows coil mass in the giant aneurysm (arrow). There is still some
residual ﬁlling of the aneurysm. (B) Lateral view shows the residual aneurysm
more clearly (arrows). The anterior cerebral arteries (ACA) were difﬁcult to
separate from the aneurysm on the angiogram, and the aneurysm was
underpacked in order to preserve these arteries. Follow-up angiography was
performed 6months after the patient made a good neurological recovery.
(C) Lateral view of the right ICA injection shows signiﬁcant recanalization
of the dome of the aneurysm (arrow). (D)The patient underwent
retreatment of the aneurysm with stent placement from the A1 segment
of the right ACA into the A2 segment of the left ACA. This was followed
by additional coil placement including gel coated coils. Subtracted view
of the right ICA injection shows a dense coil mass in the giant aneurysm
(arrow). Also note some recanalization of the right MCA aneurysm neck
(arrowhead).
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deemed technically feasbible in 38 aneurysms, with 4 being unable
to be treated due to an unfavorable dome-to-neck ratio. They
reported complete (100%) or near complete (95–99%) occlu-
sion in 34 (89.5%) aneurysms. Incomplete occlusion (< 95%) was
achieved in four aneurysms (three large and one giant).
While endovascular coiling of intracranial aneurysms has
offered an alternative treatment option to open surgery, there
are serious risks to consider. Some of these risks overlap with
those seen in open surgery and others are unique to endovascular
therapy. Murayama et al. (2003) reported procedural complica-
tions in 69 (8.45%) patients, the most common being throm-
boembolism in 24 (2.4%) patients. This percentage is also sim-
ilar to the cerebral embolization reported by Gonzalez et al.
(2004); 3.7%). Other complications include aneurysm perfora-
tion, parent artery occlusion, coil migration, arterial dissection,
and vasospasm.
A major shortcoming of aneurysm coiling, especially in the
early era of the therapy, was durability. The main etiology for
recanalization is coil compaction. Another mechanism may be
rearrangement of individual coil loops. Insufﬁcient packing of
the aneurysm neck increases the chances of aneurysm recurrence
(Raymond and Roy, 1997). The ability to increase packing density
has improvedwith the introductionof three-dimensional coils and
hydrogel coated coils that swellwhen exposed toblood.The clinical
relevance of aneurysm recanalization for endovascluar approach is
not settled unless rerupture risks for coiled aneurysms and surgical
clipping are comparable. Clinical outcomes of aneurysm coiling
are superior for small to medium size aneurysms when compared
to giant and fusiform aneurysms. A review of 46 studies encom-
passing 8,161 coiled aneurysms showed a 91% rate of adequate
occlusion at initial treatment (Ferns et al., 2009). Recanaliza-
tion was reported in 21% of aneurysms, and retreatment was
performed in 10%.
In summary, complete or near complete occlusion at initial
treatment with endovascular coiling in small aneurysms seems to
trend toward a durable result that compares favorably with the
durability of clipping. The risk of subsequent invasive procedures
must be included when considering the initial treatment of
FIGURE 3 | Balloon assisted coil embolization. A 74-year-old man with a
strong family history of aneurysmal SAH was found to have a left
ophthalmic aneurysm. (A) Lateral view of a left ICA injection shows a
7.5-mm left ophthalmic artery aneurysm (circled) with a 4.2-mm neck. The
patient underwent balloon assisted coil embolization. (B) Lateral
ﬂuoroscopic view shows the inﬂated balloon (arrow) with coils being
deployed through a microcatheter within the aneurysm. (C) AP view of the
ﬁnal left ICA injection shows no residual aneurysm.
an intracranial aneurysm. At our institution, we typically per-
form at least one follow-up angiogram at 6months. The results
of the follow-up angiogram determine the need for additional
angiograms. We have also found magnetic resonance angiogra-
phy (MRA) to be a useful alternative in detecting recanalization in
some cases.
STENT-ASSISTED COILING
Stents have been developed as an endovascular approach to open
blocked arteries in patients for re-establishing normal blood ﬂow
to tissue at risk. The ﬁrst coronary stent was implanted in a human
in 1986, and by 1999 its use had increased to 83%of all endovascu-
lar interventions in the coronary arteries (Holmes et al., 2002). The
early stents were made of stainless steel and were deployed using a
balloon catheter to mechanically force open the vessel to increase
blood ﬂow. The evolution of coronary stents eventually led to self-
expanding stents eliminating the need for balloon angioplasty to
expand the stent against the arterial wall. Material advances also
led to the development of stents comprised of super-elastic met-
als. The combination of these two technologies enabled stents to
be extremely ﬂexible and expand without the use of rigid balloon
catheters, which in turn reduces the tendency of vessel rupture
due to arterial wall damage during deployment. These improve-
ments, in conjunction with the introduction of microcatheters
andmicrowires, enabled clinicians to navigate and deliver stents to
previously inaccessible areas, more speciﬁcally the cerebral vascu-
lature. The ﬁrst stent designed for treatment of aneurysms was the
Neuroform stent, which received a Humanitarian Device Exemp-
tion from the FDA in late 2002 (Fiorella et al., 2005). The primary
objective of a stent application is to provide a scaffold for coiling
an aneurysm with difﬁcult shapes and sizes with a wide neck. A
case report of a stent-assisted coil embolization is described in
Figure 4.
FIGURE 4 | Stent-assisted coil embolization. A 64-year-old woman with
headaches and a family history of aneurysms underwent screening and a
basilar apex aneurysm was discovered. (A) AP view of a right vertebral
artery (VA) injection demonstrates the wide neck aneurysm (arrow). The
neck incorporates the origin of the left posterior cerebral artery (PCA). (B) A
Neuroform stent (Boston Scientiﬁc, Natick, MA, USA) delivery system
positioned with the proximal and distal markers (circles) visible on
ﬂuoroscopy. Coils were introduced into the aneurysm through a separate
microcatheter. (C) Final AP view shows near total occlusion of the
aneurysm and preservation of the left PCA.
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Table 1 | Immediate anatomical results from stent–assisted coiling
studies.
Author Aneurysms
treated
Complete
occlusion
Neck
remnant
Remnant
aneurysm
Fiorella et al. (2005) 61 28 (45.9%) NA 33 (54.1%)
Lubicz et al. (2008) 15 8 (53.3%) 4 (26.7%) 3 (20.0%)
Lubicz et al. (2009) 34 9 (26.5%) 2 (6.0%) 23 (67.5%)
Weber et al. (2007) 31 6 (19.3%) 18 (58.1%) 7 (22.6%)
Vendrell et al. (2011) 50 18 (36.0%) 14 (28.0%) 18 (36.0%)
Biondi et al. (2007) 40 14 (35.0%) 18 (45.0%) 8 (20.0%)
Piotin et al. (2010) 216 100 (46.3%) 41 (19.0%) 75 (34.7%)
Pierot et al. (2008) 53 23 (43.4%) 11 (20.8%) 19 (35.4%)
Total 500 206 108 186
Table 1 shows the outcomes of stent-assisted coiling studies.
Fiorella et al. (2005) were among the earliest to report results
from stent-assisted coiling immediately following the FDA lim-
ited approval use of the device for broad-neck, fusiform, or giant
aneurysms. The study included a total of 74 aneurysms in 64
patients, however only 61 aneurysms were treated with stent-
assisted coiling. Follow-up angiographic (average 4.6months)
results were available for 48 aneurysms. Eleven patients showed an
increase in residual aneurysm size, sevenof whichunderwent addi-
tional coil embolization. Residual aneurysm decreased or resolved
in 25 patients,while no changewas observed in 12 patients. Similar
results were shown by Lubicz et al. (2008) who treated 15 unrup-
tured aneurysms in 14 patients with stent-assisted coiling. All
patients showed excellent (neurologically intact) clinical outcome
after the procedure. Lubicz et al. (2009) published another study,
utilizing the Leo stent (Balt,Montmorency, France) and Enterprise
stent (Codman, J&J, Raynham, MA, USA), on long term fol-
low up of patients treated with stent-assisted coiling. Thirty-four
aneurysms, all wide-neck (neck > 4mm or neck/sac ratio > 0.7),
were treated in 32 patients. Follow up was performed at 6months
(n = 4 patients), 12months (n = 16 patients), and 36months
(n = 12 patients) with a mean of 20months. Final angiographic
results (performed between 6 and 36months) showed aneurysm
occlusion was complete in 27 (79%), neck remnant in 3 (9%), and
incomplete in 4 (12%).
Favorable results were also shown by Weber et al. (2007) for
the treatment of 31 wide-neck saccular aneurysms in 30 patients.
Successful stent placement with adequate coil positioning, with-
out any procedural complications, was achieved in 28 (90%) of
31 aneurysms. At 6months, they observed complete occlusion
in 15 (50%) aneurysms, neck remnants in 8 (26.7%) aneurysms,
and 7 (23.3%) residual aneurysms. Results also revealed that 29
(93.5%) of the parent arteries were unaffected, while 2 parent ves-
sels had minor asymptomatic narrowing at the stent site. Vendrell
et al. (2011) assessed stent-assisted coiling in 49 patients pre-
senting a total of 52 unruptured MCA aneurysms. Fifty (96.2%)
aneurysms were successfully treated; two were referred to surgery
after catheterization of the parent vessel was unsuccessful. At
a follow-up period of 14± 9months, complete treatment was
observed in 34 (71%) aneurysms, residual necks were present
in 6 (12%), and incomplete occlusion in 8 (17%). Biondi et al.
(2007) reported retrospective results of stent-assisted coiling in
the treatment of 46 wide-neck aneurysms in 42 patients, however
only 40 aneurysms were successfully treated with stents and coils.
Follow-up results of 30 aneurysms treated by stent-assisted coiling
showed 17 (57%) aneurysm occlusions, 7 (23%) presented neck
remnants, and 6 (20%) had a residual aneurysm. A recent study
published by Piotin et al. (2010) presented results on the endovas-
cular repair of 1,325 aneurysmsusing coils, including 216 thatwere
treated by stent-assisted coiling. One hundred eighty-one (83.8%)
of the aneurysms receiving a stentwereunruptured.The analysis of
angiographic follow up showed that stented aneurysms hade lower
recurrence rates vs. non-stented aneurysms. The study showed
the use of stents was beneﬁcial in terms of angiographic stabil-
ity in both ruptured (P = 0.0339) and unruptured (P = 0.0073)
aneurysms.
The analysis of treatment by endovascular approach of non-
ruptured aneurysms (ATENA), published by Pierot et al. (2008),
has been one of the most comprehensive studies on the treatment
of unruptured aneurysms. The study included 649 patients, har-
boring 739 aneurysms. Seven hundred twenty-seven aneurysms
were treated using coils (98.4%). Coils alone were used in 396
aneurysms (54.4%),withballoon remodeling in 271 cases (37.3%),
intracranial stents in 57 cases (7.8%), and the Trispan neck bridge
in 3 cases (0.4%). Treated aneurysms were divided into four size
categories; 131 (17.7%) aneurysms were 1–3mm, 304 (41.1%)
aneurysms were 4–6mm, 215 (29.1%) aneurysms were 7–10mm,
and 89 (12.0%) aneurysms were 11–15mm. Fusiform and dissect-
ing aneurysms were excluded from the study, as well as patients
who had experienced a SAH from another aneurysm within
the last month. Initial results indicated postoperative occlusion
was complete in 436 aneurysms (59.0%); neck remnant in 160
aneurysms (21.7%), and aneurysm remnant in 143 aneurysms
(19.3%). Another study by Pierot et al. (2010) further broke down
the analysis of the ATENA results for each treatment technique.
Theoutcomes basedon treatment techniques are shown inTable 2.
The ATENA study shows the viability of endovascular treatment
of unruptured aneurysms can be achieved in large number of
cases (95.7%) with low mortality and morbidity (1.4 and 1.7%,
respectively).
Stent-assisted coiling has improved the ability to treat difﬁ-
cult and complicated aneurysms since its FDA approval in 2002.
New clinical techniques continue to emerge along with advances
in-stent design. However, while these devices provide another
treatment option for endovascular repair, additional risks are
associated with stent placement compared to coiling alone. Plac-
ing a stent in the parent artery requires lifetime use of anti-
platelet agents to reduce the risk of thrombosis based stenosis
within the stent. Kanaan et al. (2010) reported acute in-stent
thrombosis or chronic stenosis in 9 of 133 stent-coil deploy-
ments (6.8%) during a mean follow up of 15.4months. The
need for anti-platelet therapy limits the role of stent placement
in patients with ruptured aneurysms. These patients may need
additional invasive procedures such as ventriculostomy, decom-
pressive craniectomy, tracheostomy, or gastrostomy. The risk of
these procedures is increased due to anti-platelet or anticoagu-
lation therapy. Mocco et al. (2009) showed a high rate of mor-
tality in patients with SAH when compared to the unruptured
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Table 2 | Immediate anatomical results by treatment technique,
ATENA study (Pierot et al., 2010).
Anatomical results Coiling Remodeling Stenting
Complete occlusion 244 (63.7%) 170 (65.9%) 23 (43.4%)
Neck remnant 85 (22.2%) 60 (23.3%) 11 (20.8%)
Remnant aneurysm 54 (14.1%) 28 (10.9%) 19 (35.8%)
Total 383 (100%) 258 (100%) 53 (100%)
cohort (12 vs. 0.8%, respectively). In the study reported by Piotin
et al. (2010), mortality rates were similarly high (6.0 vs. 1.2%
in aneurysms treated with stent and without stent, respectively).
Differences in procedural complications were also statistically
signiﬁcant (P = 0.027) when comparing results of aneurysms
treated with stent (7.4%) and those treated without a stent
(3.8%). The increase in complications translated into higher pro-
cedure related deaths (4.6 to 1.2%, P = 0.006). Long term studies
are needed to further evaluate in-stent thrombosis or steno-
sis. Due to their high porosity, stents surface area coverage of
aneurysm neck is relatively low (4 to 7%). Therefore while they
may provide improved stability for coiling, they are not sufﬁ-
cient as a stand-alone therapy of the majority of intracranial
aneurysms.
FLOW DIVERSION
With advent of computational ﬂuid dynamics over the past few
decades,more andmore research has begun focusing on advancing
aneurysm treatment options. Improvement in imagingmodalities
has greatly inﬂuenced medical device design. The latest neuroen-
dovascular devices for treating intracranial aneurysms to reach the
market are ﬂow diverters. So far, limited clinical approval has been
achieved on any such device, but procedures are performed under
FDA exemption for compassionate use (Fiorella et al., 2008). The
primary goal of a ﬂow diversion device is to divert ﬂow away from
the aneurysm by placing amesh structure, similar to a stent, on the
aneurysm neck along the parent artery. By decoupling blood ﬂow
between the parent artery and aneurysmal sack, a ﬂow diverter
can create blood stasis to allow for thrombus formation inside the
aneurysm. Flowdiverters are intended to be used in anatomical sit-
uationswhere stent-assisted coiling becomes difﬁcult, such as giant
or fusiform aneurysms. In terms of design, they are very similar to
stents, consisting of a highly ﬂexible tubular structure with amesh.
They differ in one major aspect, the porosity of the cells or mesh
is less than typical stents. Therefore, the major focus in manufac-
turing design for ﬂow diverters has been shift from radial force
exerted by the stent on the vessel wall to ﬂow alternation inside
the aneurysm (from solid mechanics to ﬂuid mechanics). These
scaffolds, or constructs, are speciﬁcally designed for use in the
neurovasculature, where as stent design evolved from its original
coronary application.
Lylyk et al. (2009) were among the ﬁrst to report large clinical
results on the use of ﬂow diverters in 53 patients harboring 63
aneurysms. Immediate angiographic results showed only 5 of 63
(8%)were completely occluded,all of whichwere small (< 10mm)
aneurysms. Complete angiographic occlusion was achieved in
56% at 3months (n = 42), 93% at 6months (n = 28), and 95%
at 18months (n = 18) follow up. Szikora et al. (2010) reported
results for 19 wide-neck aneurysms in 18 patients; however their
study included 10 aneurysms treated with coil packing in addition
to the use ﬂow diverters. Six month follow up of 18 aneurysms
revealed 17 complete occlusions.
Kulcsar et al. (2010) reported the use of ﬂow diversion devices
in 12 basilar artery aneurysms. Short term (< 32weeks) follow up
indicated that 7 of 12 (58%) of the treated aneurysms had com-
pletely occluded. Lubicz et al. (2010) successfully delivered a ﬂow
diverter device in 26 of 29 (90%) patients harboring 34 unrup-
tured aneurysms. Mortality andmorbidity rates were 4% (1 of 26)
and 15% (4 of 26), respectively. Immediate anatomic outcomes,
assessed by angiographic imaging, included complete stasis in 4
aneurysms (12.9%), signiﬁcant ﬂow reduction in 13 aneurysms
(41.9%), slow ﬂow in 13 aneurysms (41.9%), and unchanged ﬂow
in 1 aneurysm. Follow-up angiographic results were available in 24
patients with 29 aneurysms at 6 (n = 12) and 12 (n = 12) months.
Results showed 20 complete occlusions (69%), 1 neck remnant
(3.5%), and 8 incomplete occlusions (27.5%). Byrne et al. (2010)
collected data for 70 patientswhere 60 patientswere treated byﬂow
diversion device only, and 10 were treated with a ﬂow diverter and
coils combination. Angiographic assessment at the end of treat-
ment, for the 68 successful interventions (in 67 patients), showed
complete occlusion in 7 (10%), neck remnant in 4 (6%), and
residual sac ﬁlling in 57 (84%). They reported follow-up angiog-
raphy in 49 (72%) aneurysms, all but 2 showed no change or
improvement.
Current research continues to materialize on the use of ﬂow
diverters to treat intracranial aneurysms. These devices are typ-
ically deployed in situations where established techniques, such
as coiling and stent-assisted coiling, are not viable options. It
is not surprising that with increased technical demands, comes
increased technical complications with deployment of ﬂow divert-
ers. Lubicz et al. (2010) reported an overall complication rate of
38%, including parent artery stenosis, distal embolism, in-device
thrombosis, branch occlusion, and hemorrhage or mass effects.
They also reported parent artery stenosis in eight cases (33%) at
follow up. In another study, parent artery occlusion was seen in
seven (14%) patients, with additional arterial narrowing in three
(6%) patients (Byrne et al., 2010).
Stents used for coil stability do not substantially reduce blood
ﬂow to the aneurysm sack as compared to ﬂow diverters. Clin-
icians must use caution in deployment of ﬂow diverters when
aneurysms are located near regions of side branching arteries.
Incorrect placement could prevent blood ﬂow to an otherwise
healthy artery. Another concern with ﬂow diverters is the low
porosity, needed to reduce blood ﬂow, will be problematic if addi-
tional coiling is needed after deployment due to the small open
spaces in the mesh. Anti-coagulants required for ﬂow diverters
may be beneﬁcial for prevention of in-device thrombus, but could
negatively impact the time for thrombus formation inside the
aneurysm without the additional coil packing used with stents.
The interaction of thrombus formation inside aneurysms is not
clearly understood and has been suggested it could lead to rup-
ture after deployment of a ﬂow diverter (Kulcsar et al., 2011). The
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mechanisms behind this phenomenon could relate to a reduc-
tion in WSS below normal physiological values (Boussel et al.,
2008), leading to vessel remodeling and rupture. Endovascular
treatment of intracranial aneurysms using ﬂow diverters is a rel-
atively novel approach, with a small number of clinical results
available, and more information is needed to fully evaluate the
effectiveness. It should be noted that Pipeline EmbolizationDevice
(PED), owned by Covidien, Mansﬁeld, MA, USA (previously
owned by eV3, Inc./Chestnut Medical Technologies, Inc., Menlo
Park, CA,USA) has recently been approved by the FDANeurolog-
ical Devices Advisory Panel as ﬂow diversion device for treatment
of aneurysms, and is currently awaiting a ﬁnal decision by the FDA
committee.
COMPARISON OF SURGICAL CLIPPING AND COIL EMBOLIZATION
The advent of endovascular therapy has certainly reduced the role
of open surgery. For some aneurysms, endovascular treatment is
preferred, whereas for others surgery is still superior in both cost
and outcomes (Chicoine, 2003; Takao andNojo, 2007). The choice
of open surgery vs. endovascular surgery for aneurysms, whether
ruptured or unruptured, remains an individualized decision. The
following factors play a role in treatment decisionmaking: (1) age,
past medical history, and medical/neurological conditions help to
determine the patient’s ability to tolerate a speciﬁc treatment. For
example, a patient with a ruptured aneurysm in poor neurologi-
cal condition likely has a diffusely swollen, friable brain, and coil
embolization may be superior to surgery in this setting. On the
other hand, a young patient with an unruptured aneurysm may
be a good candidate for open surgery in anticipation of achieving
a durable result. In some instances, patient preference also plays
a role in which treatment is chosen. (2) Aneurysm characteristics
such as location (suitability for surgical access), morphology, and
size. Basilar apex aneurysms are associated with higher surgical
morbidity compared to other locations, so endovascular treat-
ment is usually the preferred choice of treatment. On the other
hand, MCA aneurysms tend to have complex morphologies with
wide necks and important arterial branches may be incorporated
into the aneurysm. These aneurysms tend to be more suitable
for open surgery. A ruptured aneurysm with a large intracere-
bral hematoma and mass effect may be better suited for surgery.
(3) Finally, operator preferences are often understated but equally
important. This includes the operator’s bias toward a certain
treatment because of experience and familiarity. Some complex
aneurysms may require a combination of open and endovascular
surgeries.
The International subarachnoid aneurysms trial (ISAT) was a
randomized, multicenter study that compared clinical outcomes
of patients presentingwith ruptured aneurysms, and treated either
by clipping or by coiling (Molyneux et al., 2002). A total of 9,559
patients with SAH were assessed, and 2,143 patients were ulti-
mately enrolled and randomized. Initial clinical outcomes from
ISAT indicated little difference between endovascular and surgical
treatment.However, the results at 1 year followupwere convincing
enough to lead to an early termination of the study, because those
treated with endovascular coiling had a 6.9% absolute risk reduc-
tion and 22% relative risk reduction in poor outcome compared
with surgical clipping (Molyneux et al., 2002). Long term follow
ups in ISAT indicated endovascular coiling had a higher risk of re-
bleeding than clipping, but the risk was low and remained similar
to risk of SAH from another aneurysm (Molyneux et al., 2009).
The ISAT study indicated that endovascular treatment was a safe
and effective alternative to surgical treatment for certain ruptured
aneurysms. However, the results were not sufﬁcient to determine
that endovascular treatment is superior to surgical treatment in
all patients with ruptured aneurysms and cannot be applied to
unruptured aneurysms. The trial demonstrated that coil emboliza-
tion resulted in less peri-procedural morbidity in a selected group
of patients. Retreatment was performed in 17.4% of the 1,096
patients who underwent endovascular therapy and in 3.8% of
the 1,012 patients who underwent surgical clipping (Campi et al.,
2007).
A recent study reported by Alshekhlee et al. (2010) com-
pared hospital mortality and complication rates associated with
aneurysm clipping and coiling based on the National Inpatient
Sample (NIS) between 2000 and 2006. A total of 3,738 patients
had aneurysm clipping and 3,498 had endovascular coiling. For
clipping vs. endovascular coiling, both median length of hos-
pital stay (4 and 1 days, respectively, P < 0.0001) and mortality
(1.6 vs. 0.57%, respectively) were higher. The study also presented
data showing a trend in hospital use of endovascular coiling has
increased during recent years. Singh et al. (2002) showed that
increased clinician experience with endovascular coiling resulted
in decreased risk of complications. The combination of these fac-
tors may be advantageous for endovascular treatment were similar
comparative studies to be conducted.
DISCUSSION
Advances in imaging modalities and knowledge of natural his-
tory and prevalence of aneurysms have increased detection of
unruptured asymptomatic intracranial aneurysms. An unbiased
assessment of most appropriate course of treatment is crucial for
achieving a favorable outcome. The size of an aneurysm has been
associated with higher risk of complications for both surgical and
endovascular treatment approach (Johnston et al., 2002). Stud-
ies reporting on the risk of rupture and outcomes have provided
much insight but the debate remains of how and when unrup-
tured aneurysms should be managed. The studies reviewed here
support the generalized notion that endovascular treatment of
UIA provides a safe and effective alternative to surgical treat-
ment. The risks associated with endovascular repair are lower and
incur shorter hospital stays for appropriately selected patients.
The method of endovascular treatment should be considered
based on factors such as aneurysm size, location, patient med-
ical history, and clinician experience. To date, there have been
no randomized large studies comparing outcomes using differ-
ent endovascular options. The likeliness of such a study appears
slim as the variability in the use of devices is wide. Further-
more, the rapid development of endovascular technology often
prevents adequate appraisal of existing devices andmethods. Cur-
rently, endovascular therapy and surgical therapy must be viewed
as complementary rather than competitive in the treatment of
intracranial aneurysms.
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